Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians

by Spadi, Rosella, Brusa, Federica, Ponzetti, Agostino, Chiappino, Isabella, Birocco, Nadia, Ciuffreda, Libero, Satolli, Maria Antonietta
Published in World J Clin Oncol (2016)

Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept

by Pelosi, Giuseppe, Massa, Federica, Gatti, Gaia, Righi, Luisella, Volante, Marco, Birocco, Nadia, Maisonneuve, Patrick, Sonzogni, Angelica, Harari, Sergio, Albini, Adriana, Papotti, Mauro
Published in Clin Pathol (2019)

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

by Brizzi, Maria P, Berruti, Alfredo, Ferrero, Anna, Milanesi, Enrica, Volante, Marco, Castiglione, Federico, Birocco, Nadia, Bombaci, Sebastiano, Perroni, Davide, Ferretti, Benedetta, Alabiso, Oscar, Ciuffreda, Libero, Bertetto, Oscar, Papotti, Mauro, Dogliotti, Luigi
Published 2009

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study

by Berruti, Alfredo, Fazio, Nicola, Ferrero, Anna, Brizzi, Maria Pia, Volante, Marco, Nobili, Elisabetta, Tozzi, Lucia, Bodei, Lisa, Torta, Mirella, D’Avolio, Antonio, Priola, Adriano Massimiliano, Birocco, Nadia, Amoroso, Vito, Biasco, Guido, Papotti, Mauro, Dogliotti, Luigi
Published 2014